Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer

British Journal of Surgery

Volumn 98, Issue 6, 2011, Pages 768-783

  Kranzfelder, M ^a   Schuster, T ^b   Geinitz, H ^a   Friess, H ^a   Buchler P ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; ESOPHAGUS TUMOR; HUMAN; META ANALYSIS; MIDDLE AGED; MORTALITY; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; HUMANS; MIDDLE AGED; PATIENT CARE TEAM; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79955485070     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7455     Document Type: Article

References (54)

1. Siewert JR, Ott K,. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol 2007; 17: 38-44. (Pubitemid 44918361)
2. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J,. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-234. (Pubitemid 46291702)
3. Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, et al., Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-1168. (Pubitemid 46640561)
4. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al., Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-2317. (Pubitemid 46218723)
5. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS,. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003; 10: 754-761. (Pubitemid 40486875)
6. Urschel JD, Vasan H,. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543. (Pubitemid 36627845)
7. Graham AJ, Shrive FM, Ghali WA, Manns BJ, Grondin SC, Finley RJ, et al., Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 2007; 83: 1257-1264. (Pubitemid 46440778)
8. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR,; Hedges Team. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 2005; 330: 1179.
9. Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, Venturi A, et al., Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004; 53: 925-930. (Pubitemid 38824146)
10. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD,. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005; 137: 172-177. (Pubitemid 40174424)
11. Malthaner RA, Wong RK, Rumble RB, Zuraw L,. Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med 2004; 2: 35.
12. Apinop C, Puttisak P, Preecha N,. A prospective study of combined therapy in esophageal cancer. Hepatogastro-enterology 1994; 41: 391-393. (Pubitemid 24273251)
13. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al., Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167. (Pubitemid 27306287)
14. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, et al., Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668. (Pubitemid 41222756)
15. Cao XF, He XT, Ji L, Xiao J, Lv J,. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus 2009; 22: 477-481.
16. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al., A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-1784. (Pubitemid 24101950)
17. Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, et al., A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004; 15: 947-954. (Pubitemid 39004352)
18. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al., Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-1109.
19. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al., Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-1092.
20. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M,. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-313. (Pubitemid 32112841)
21. Walsh T,. The role of multimodality therapy in improving survival: a prospective randomised trial. In Predicting, Defining and Improving Outcomes for Oesophageal Carcinoma (MD Thesis). Dublin Trinity College, University of Dublin: Dublin, 1995.
22. Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Yokomakura N, et al., Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus 2006; 19: 468-472. (Pubitemid 44644683)
23. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733.
24. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE,. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009; 27: 5062-5067.
25. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al., Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984. (Pubitemid 29024130)
26. Law S, Fok M, Chow S, Chu KM, Wong J,. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997; 114: 210-217.
27. Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaang S, et al., Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994; 56: 191-197. (Pubitemid 24226640)
28. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S,. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988; 96: 242-248.
29. Schlag PM,. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 1992; 127: 1446-1450.
30. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al., Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91: 2165-2174. (Pubitemid 32476382)
31. Chiu PW, Chan AC, Leung SF, Leong HT, Kwong KH, Li MK, et al., Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005; 9: 794-802. (Pubitemid 40883974)
32. Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, et al., A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol 2005; 58: 1233-1240. (Pubitemid 41608539)
33. Downs SH, Black N,. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384. (Pubitemid 28438523)
34. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. (Pubitemid 26120810)
35. Schulz KF, Chalmers I, Hayes RJ, Altman DG,. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
36. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2. [accessed 10 May 2010].
37. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F,. Systematic reviews of trials and other studies. Health Technol Assess 1998; 2: 1-276.
38. Parmar MK, Torri V, Stewart L,. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834. (Pubitemid 28562978)
39. Moher D, Liberati A, Tetzlaff J, Altman DG,; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
40. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al., Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003; 21: 4592-4596. (Pubitemid 46594032)
41. Baba M, Natsugoe S, Shimada M, Nakano S, Kusano C, Fukumoto T, et al., Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 2000; 13: 136-141.
42. Tachibana M, Yoshimura H, Kinugasa S, Shibakita M, Dhar DK, Ueda S, et al., Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Eur J Surg Oncol 2003; 29: 580-587. (Pubitemid 37121758)
43. Ancona E, Cagol M, Epifani M, Cavallin F, Zaninotto G, Castoro C, et al., Surgical complications do not affect longterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. J Am Coll Surg 2006; 203: 661-669. (Pubitemid 44648779)
44. Krause BJ, Herrmann K, Wieder H, zum Büschenfelde CM,. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer. J Nucl Med 2009; 50 (Suppl 1): 89S-96S.
45. van Heijl M, van Lanschot JJ, Koppert LB, van Berge Henegouwen MI, Muller K, Steyerberg EW, et al., Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008; 8: 21.
46. Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB,. Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies. Ann Oncol 1996; 7: 355-359. (Pubitemid 26246786)
47. Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH,. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol 2009; 15: 5983-5991.
48. Malthaner RA, Collin S, Fenlon D,. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2006; (3)CD001556.
49. Urschel JD, Vasan H, Blewett CJ,. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002; 183: 274-279. (Pubitemid 34273984)
50. Malthaner R, Fenlon D,. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2003; (4)CD001556.
51. Arnott SJ, Duncan W, Gignoux M, Hansen HS, Launois B, Nygaard K, et al., Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 2005; (4)CD001799.
52. Pultrum BB, Honing J, Smit JK, van Dullemen HM, van Dam GM, Groen H, et al., A critical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol 2010; 17: 812-820.
53. Deeter M, Dorer R, Kuppusamy MK, Koehler RP, Low DE,. Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. Arch Surg 2009; 144: 618-624.
54. Royal College of Pathologists. Dataset for the Histopathological Reporting of Oesophageal Carcinoma (2nd edn). Royal College of Pathologists: London, 2006.